September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Randomized phase III trial of adjuvant carboplatin and paclitaxel in epithelial ovarian cancer
Feb 1, 2025, 16:18

Randomized phase III trial of adjuvant carboplatin and paclitaxel in epithelial ovarian cancer

Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute, shared an article by Jeffrey Bell, et al. on X:

“Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian cancer:

GOG 157: 3 cycles of chemo may be sufficient for high risk early stage EOC.”

Randomized phase III trial of adjuvant carboplatin and paclitaxel in epithelial ovarian cancer

Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: a Gynecologic Oncology Group study.

Authors: Jeffrey Bell, et al.

Randomized phase III trial of adjuvant carboplatin and paclitaxel in epithelial ovarian cancer